Global health funding slows as deadline for Millennium Development Goals nears

December 14, 2011

SEATTLE - Developed countries and funding agencies are putting the brakes on growth in development assistance for health, raising the possibility that developing countries will have an even harder time meeting the Millennium Development Goal deadline looming in 2015, according to new research from the Institute for Health Metrics and Evaluation at the University of Washington.

Even as aid continued to grow, reaching $27.73 billion in 2011, significant cutbacks in the United States slowed the growth rate in development assistance to 4% between 2010 and 2011 - the slowest rate in a decade.

The new findings are being published online today as a Web First article in Health Affairs, The global financial crisis has led to a slowdown in growth of funding to improve health in many developing countries, and in the latest installment of IHME's financing series, Financing Global Health 2011: Continued Growth as MDG Deadline Approaches.

The report details the trends in development assistance for health between 1990 and 2009 from aid agencies and governments in 23 developed countries, multilateral institutions such as the World Health Organization, and hundreds of nonprofit groups and charities with preliminary estimates for 2010 and 2011. It also captures spending by countries from 1995 to 2009. The detailed results of the IHME analysis are being made available in IHME's Global Health Data Exchange (GHDx), along with project-level data that can be used to answer a variety of research questions.

"Even though we continue to see growth in global health funding through 2011, it is troubling to see so many funders pulling back," said Dr. Christopher Murray, IHME Director and one of the report's authors. "We are just now beginning to see the impact from the extraordinary growth in global health funding over the past decade. If we give up now, we may lose that momentum."

IHME reported in September 2011 that most of the world's countries are reducing child mortality and maternal mortality more quickly than a decade ago. The Institute also found that an HIV program in India called Avahan appears to have prevented 100,000 infections. In August 2011, IHME and collaborators found that in homes that own at least one insecticide-treated bed net there was a 23% reduction in child mortality. The Institute is working on new research examining the relationship between development assistance for health and health outcomes in a broad range of areas.

Most of the growth in development assistance for health over the past two years came from the World Bank's International Bank for Reconstruction and Development, which greatly expanded its loans to middle-income countries as the economic crisis worsened in 2009. Health funding through United Nations agencies plateaued in 2011, and the Global Fund to Fight AIDS, Tuberculosis and Malaria announced in November that it would make no new grants until 2014 due to funding shortfalls. Preliminary estimates indicate that health assistance channeled through the Global Fund declined by $529 million, or 16%, between 2010 and 2011.

"Even with so many economies in turmoil, we are seeing strong commitments to global health from many countries," said Katie Leach-Kemon, IHME's Data Development Manager and a co-author of the Health Affairs article and the Financing Global Health 2011 report. "The UK increased its development assistance for health by double digits in 2011. Germany has started to increase funding again after cutting back, and Norway has consistently been one of the leaders in donating a substantial portion of its budget every year to global health efforts."

There are several other key findings from the report: "Ultimately, whether health outcomes improve within a country will be determined by how that country sets priorities," said Dr. Michael Hanlon, one of the report's co-authors and the head of IHME's Health Financing team. "Over time, we are seeing an increase in the amount of health funding shifted to other areas. In the current economic climate, it is critical for policymakers to keep a close eye on these trends and to evaluate the impact that fluctuating spending levels are having on population health."
-end-
The Institute for Health Metrics and Evaluation (IHME) is an independent global health research center at the University of Washington that provides rigorous and comparable measurement of the world's most important health problems and evaluates the strategies used to address them. IHME makes this information freely available so that policymakers have the evidence they need to make informed decisions about how to allocate resources to best improve population health. We conduct our research free from the influence of the governments and organizations implementing the programs being studied. For the report and for more information about IHME, please visit http://www.healthmetricsandevaluation.org

Institute for Health Metrics and Evaluation

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.